Cart 0
 

Leading the Pack in Companion Animal Oncology

Torigen Pharmaceuticals
 
iStock-578593548.jpg

Harnessing the Immune System to Fight Cancer

 

Immunotherapies are growing traction in both the human and veterinary market as a sole, or adjunct treatment to chemotherapy and/or radiation. With over 10 years of supporting pre-clinical research, our treatment is a whole cell tissue vaccine. Treatments like these allow for a variety of tumor associated antigens to be presented to the immune system. This abundant choice of antigens may increase the likelihood of a successful response.

 

Immunotherapeutic approaches to cancer are emerging that will complement surgery, radiation therapy and chemotherapy by generating specific adaptive immunity to both tumor cells and altered host tissues. Tumors evade normal immune surveillance mechanisms through a variety of means. Some of these include interfering with dendritic cell antigen presentation, down regulation of cytokines that can destroy tumor cells, stimulation of regulatory (suppressor) T cells, and by altering host tissue to further mask it from the immune system. Our goal at Torigen is to develop innovative veterinary cancer treatments that allow for the body to recognize tumor-associated antigens as foreign and overcome immune senescence. 

Torigen Logo.png

Our experimental autologous cancer vaccine uses the animal's own tumor cells to create a personalized immunotherapy

 
iStock-546200402.jpg

Our 3-Step
Submission
Process

Three easy steps to getting the personalized autologous cancer vaccine for an animal in your care.

3-step icon.png
 

Step 1 :

Excise the tumor and send it to our lab using our pre-paid overnight shipping service

Chemistry with white fade.png

Step 2 : 

We prepare the personalized vaccine and send it back to your clinic within 72 hours via overnight shipping

 
Delivery_icon.png

72 Hours

 

Step 3 :

Administer the personalized treatment by subcutaneous injection (1mL) once per week, for 3 weeks

Molecule with white fade.jpg
 

Ready to Take Action?

 
 

Are you interested in offering our experimental autologous cancer vaccine as an option for the animals in your care?